Immune Checkpoint Inhibitors in Hodgkin Lymphoma
Sort by:
Stephen M. Ansell
Updates in the Treatment of Frontline and R/R cHL: Clinical Application to Practice
- 6 views
- March 20, 2025
- 1
OncoPharm
Landmark Clinical Trial Insights: SWOG S1826 for Advanced Stage cHL & GCIG INTERLACE Locally Advanced Cervical Cancer
FEATURING
John Bossaer
- 24 views
- February 14, 2025
University of Miami Sylvester Comprehensive Cancer Center
ASH & ISHL 2024 Summary: Key Clinical Questions & Highlights in cHL
FEATURING
Craig Moskowitz
- 175 views
- February 6, 2025
- 6
Cleveland Clinic Taussig Cancer Institute
ASH 2024 Review: Key Updates in Hodgkin Lymphoma
FEATURING
Molly Gallogly
- 424 views
- February 3, 2025
- 4
ecancer
ASH 2024 Insights: Outcomes of Pembro in Low-Risk Pediatric cHL With Slow Early Response to 1L Chemo
FEATURING
Christine Mauz-Körholz
- 11 views
- January 21, 2025
Memorial Sloan Kettering Cancer Center
ASH 2024 Insights: Pembro Maintenance instead of ASCT for Pts With R/R cHL in CR After Pembro-GVD
FEATURING
Alison Moskowitz
- 220 views
- January 15, 2025
- 3
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment Options for R/R HL: Case Presentation and Discussion
FEATURING
Shahla Shabanova
- 17 views
- October 8, 2024
University of Miami Sylvester Comprehensive Cancer Center
Current Treatment of 1L Hodgkin Lymphoma
FEATURING
Craig Moskowitz
- 597 views
- August 2, 2024
- 2
UChicago Medicine
Are Checkpoint Inhibitors the SOC in Frontline Hodgkin Lymphoma?
FEATURING
Boyu Hu
- 36 views
- July 29, 2024
- 1
UChicago Medicine
Clinical Case Discussions in Hodgkin's Lymphoma
FEATURING
Kaitlin Kelly,
Grace Rivera
- 47 views
- July 29, 2024
UChicago Medicine
Current Standard of Care in Second Line Treatment for Hodgkin Lymphoma
FEATURING
Sarah Rutherford
- 59 views
- July 29, 2024
UChicago Medicine
Special Considerations in Adolescent and Young Adult Patients: Insights on HL and PMBCL
FEATURING
Ann LaCasce
- 25 views
- July 22, 2024
UChicago Medicine
Managing Toxicity in Pts With cHL Receiving Checkpoint Inhibitors or ADCs
FEATURING
Rebecca Follenweider
- 28 views
- July 22, 2024
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Limited Stage HL - Current SOC, Future Directions, and Incorporating BV and Nivo
FEATURING
Steven Park
- 63 views
- July 18, 2024
- 1
SOHO Brazil 2024
Summary of Recent Updates in Advanced Hodgkin Lymphoma
FEATURING
Craig Moskowitz
- 220 views
- July 11, 2024
- 2
SOHO Brazil 2024
Summary of Recent Updates in R/R HL
FEATURING
Craig Moskowitz
- 133 views
- July 11, 2024
- 1
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Treatment of Advanced Stage, High-Risk Hodgkin's Lymphoma With AVD+BV+Nivo
FEATURING
Maher Salamoon
- 172 views
- July 9, 2024
- 5
Total Health
Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL, MM, and CLL
FEATURING
Marcello Maria Rotta
- 353 views
- July 8, 2024
